5JF-86891-24200
4 vaccinations
4 coded responses
39 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 606 / IL
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- 3GH-98681-77511
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-26
Registered in v-safe
-
2022-08-05
Dose 1 — Pfizer-BioNTechCo-administered: Hib:Polio:Rotavirus:Tetanus
-
2022-08-09
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-08-10
-
2022-08-11
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-08-12
- 2022-08-19
- 2022-08-27
-
2022-09-02
Survey response — day 28, dose 1, under 3MedDRA: Cough, Nasal congestion, Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: A cold - stuffy nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-03
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-03
- 2022-09-04
- 2022-09-06
- 2022-09-07
- 2022-09-08
- 2022-09-09
- 2022-09-10
- 2022-09-17
- 2022-09-24
-
2022-10-01
Survey response — day 28, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-15
-
2022-11-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu:Hepatitis B
-
2022-11-07
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-11-08
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Fair · Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-11-09
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-11-10
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
-
2022-12-09
Survey response — day 35, dose 3, under 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend schoolFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-12-16
- 2023-02-03
- 2023-05-05
-
2023-05-12
Dose 4 — Pfizer-BioNTechCo-administered: Hib:Pneumonia:Tetanus
- 2023-05-17
- 2023-05-18
- 2023-05-19
- 2023-05-26
-
2023-06-02
Survey response — day 21, dose 4, under 3MedDRA: Decreased appetite, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-06-09
- 2023-06-16
- 2023-06-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-05 | Pfizer-BioNTech | Hib:Polio:Rotavirus:Tetanus |
| 2 | 2022-09-03 | Pfizer-BioNTech | Flu |
| 3 | 2022-11-04 | Pfizer-BioNTech | Flu:Hepatitis B |
| 4 | 2023-05-12 | Pfizer-BioNTech | Hib:Pneumonia:Tetanus |
Free text
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: A cold - stuffy nose and cough
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Cold
Release 12 (Under 3) — day 35, dose 3, under 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release